Evidence map›Paper›PMID 30866836›Full record

SynthesisBMC infectious diseases2019

Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies.

Animut Alebel, Amsalu Taye Wondemagegn, Cheru Tesema, Getiye Dejenu Kibret, Fasil Wagnew, Pammla Petrucka, Amit Arora, Amare Demsie Ayele, Mulunesh Alemayehu, Setegn Eshetie

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Animut AlebelCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia. animut.a23@gmail.com.ORCID http://orcid.org/0000-0003-2822-2062
Amsalu Taye WondemagegnCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Cheru TesemaCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Getiye Dejenu KibretCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Fasil WagnewCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Pammla PetruckaCollege of Nursing, University of Saskatchewan, Saskatoon, Canada.
Amit AroraSchool of Science and Health, Western Sydney University, Penrith, NSW, 2751, Australia.
Amare Demsie AyeleCollege of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Mulunesh AlemayehuCollege of Health Sciences, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.
Setegn EshetieCollege of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis and diabetes mellitus are significant global public health challenges. In Sub-Saharan Africa, study findings regarding prevalence of diabetes mellitus amongst tuberculosis patients have been inconsistent and highly variable. Therefore, this systematic review and meta-analysis estimates the overall prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa.

methodsFour international databases (PubMed, Google Scholar, Science Direct and Cochrane Library) were systematically searched. We included all observational studies reporting the prevalence of DM among TB patients in Sub-Saharan Africa. All necessary data for this review were extracted using a standardized data extraction format by two authors (CT and AA1). STATA Version 14 statistical software was employed to conduct meta-analysis. The Cochrane Q test statistics and I

resultsIn the meta-analysis, sixteen studies fulfilled the inclusion criteria and were included. The findings of these 16 studies revealed that the pooled prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa was 9.0% (95% CI: 6.0, 12.0%). The highest prevalence of diabetes mellitus among tuberculosis patients was found in Nigeria (15%), followed by Tanzania (11%), and then Ethiopia (10%). Besides, the prevalence of diabetes mellitus among HIV infected TB patients was (8.9%) which is slightly higher than HIV uninfected (7.7%) TB patients.

conclusionDiabetes mellitus among tuberculosis patients in Sub-Saharan Africa was significantly high. Moreover, this study found that there was a high prevalence of DM among HIV infected than uninfected TB patients. It is strongly recommended to screen for DM among TB patients and special emphasis should be given for early screening of DM among TB/HIV co-infected patients.

Indexed as

Diabetes ComplicationsTuberculosisAfrica South of the SaharaHumansObservational Studies as TopicPrevalenceSub-Saharan AfricaTuberculosisType1/type 2 diabetes mellitus

Identifiers

PMID30866836
PMCPMC6417234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.